“These long-term results from the study are very encouraging,” said John Guy, M.D., the principal investigator of the study. The study, conducted at Bascom Palmer Eye Institute of the University of Miami Miller School of Medicine, involved 14 patients with LHON, a disorder caused by genetic defects inside mitochondria, the energy factories inside cells, that results in rapid, permanent and bilateral loss of vision in people of all ages, but primarily men ages 20-40. for a mitochondrial disease, Leber Hereditary Optic Neuropathy (LHON), initiated in 2014, showed low and medium doses improved visual acuity in most patients when treated within one year of onset of visual loss. Bascom Palmer faculty members also staff the Miami and West Palm Beach Veterans Affairs Medical Centers, Jackson Memorial Hospital, and Nicklaus Children’s Hospital.Long-term results of the first-ever gene therapy clinical trial in the U.S.

With five patient care facilities in Florida (Miami, Palm Beach Gardens, Naples, Plantation, and Coral Gables), the Institute serves as the Department of Ophthalmology for the University of Miami Miller School of Medicine and is directed by Eduardo C. Each year, more than 260,000 patients with nearly every ophthalmic condition are treated, and more than 16,000 surgeries are performed. In addition to its international reputation as one of the premier providers of eye care in the world, Bascom Palmer is the largest ophthalmic care, research and educational facility in the southeastern United States. News & World Report, an honor it has received for the 19th time, and by Ophthalmology Times.

Bascom Palmer Eye Institute, part of University of Miami Hospital and Clinics, is ranked the nation’s best in ophthalmology by U.S.

Bascom palmer west palm beach